Event will feature insights on LX9211, Lexicon’s novel, investigational, non-opioid treatment, as well as expert panel and Q&A session on…
BERKELEY HEIGHTS, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…
Awards in favour of Quantum BioPharma Total Approximately $3 Million TORONTO, ON / ACCESS Newswire / January 17, 2025 /…
Clinically Proven Myostatin-Targeting Formula to Enhance Muscle Growth, Repair, and Endurance MADRID, SPAIN / ACCESS Newswire / January 16, 2025…
Seasoned healthcare executive to spearhead growth strategies and market expansion as PeopleOne Health brings its innovative value-based care model to…
Winning startups across the pet industry – from veterinary care to treats and e-commerce – will compete for an additional…
Cellev8's Brand Expands Beyond Consumers WELLINGTON, FLORIDA / ACCESSWIRE / January 15, 2025 / Cellev8 Nutrition Inc., a leader in…
EMERYVILLE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing…
– David Beckham Co-Founded Premium Supplements Brand Sets the Standard for Science-Backed Excellence – Tested for 280+ banned substances, trusted by…